Compared to the general population, women with a deleterious BRCA1 or BRCA2 mutation had a roughly 2.5-fold greater risk of getting uterine cancer, according to the cohort study on the rate of BRCA mutation in uterine cancer. The gene discussed is BRCA1; the disease is uterine cancer.